One concern regarding big data is the possible compromise of personal information. This has been seen by data breaches of large financial companies resulting in stolen sensitive information such as customer names and credit card numbers. Is "data theft" a legitimate concern with big data analytics? If so, what can be done to protect such a large volume of protected patient information? 
Information security should be a concern of everyone who handles sensitive data. Virtually everyone who practices medicine in the United States is now part of a vast medical informatics web accessing large data repositories such as their hospital or practice electronic medical record (EMR)
How do big data analytics protect against data mining or simply looking through a large volume of information simply to identify associations that may or may not be real? 
"Data mining" is an older term for big data analytics that is now rarely used in the field because over time it became synonymous with "data dredging" or digging up spurious correlation. It is in nobody's interest to find spurious correlations and report them as causal connections. Much of the "analytics" part of big data analytics is dedicated to finding true correlation and minimize spurious correlation. We introduce the reader to

The "open data" or "open science" movement, spearheaded by such organizations as the National Institutes of Health (NIH), makes one of its key objectives the free and open access to the raw data used in studies. Open access gives the larger community the opportunity to critically evaluate a piece of published research from the ground up. Under this paradigm, there is no hiding behind fancy mathematical tricks because clinicians, biostatisticians, and data scientists alike all have the chance to find the flaws (and new opportunities) in any particular piece of published research. You may very well soon find yourself in an era where you may not personally be able to verify the validity of a piece of published research and yet we, all of us together, can.
Question 5:
In your opinion, who should own the rights to the repositories of data? Health systems, electronic medical record software companies, the public? Response from Dr. Macedonia:
Question 6:
You mention that cost is one of the limitations of randomized controlled trials. Are big data analytics cheaper to perform? There seems to be a significant cost to obtaining EMRs, salary time to record all the data, software to analyze the data, and a computer powerful enough to perform the computations. Is there any published information to suggest that one research method is more cost efficient than the other? 
